|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
35,915,000 |
Market
Cap: |
5.05(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$36.74 - $145.96 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
2,500 |
2,500 |
Total Buy Value |
$0 |
$0 |
$155,000 |
$155,000 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
406,079 |
504,936 |
581,965 |
1,242,554 |
Total Sell Value |
$46,236,617 |
$54,479,102 |
$60,237,739 |
$97,463,776 |
Total People Sold |
7 |
7 |
8 |
11 |
Total Sell Transactions |
28 |
43 |
55 |
134 |
End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hassanein Waleed H |
President & CEO |
|
2021-03-10 |
4 |
OE |
$2.21 |
$77,365 |
D/D |
35,007 |
373,850 |
|
- |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2021-03-08 |
4 |
AS |
$32.00 |
$640,000 |
D/D |
(20,000) |
46,076 |
|
-14% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2021-03-08 |
4 |
OE |
$0.28 |
$5,600 |
D/D |
20,000 |
66,076 |
|
- |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2021-03-05 |
4 |
AS |
$30.45 |
$618,099 |
D/D |
(20,000) |
46,076 |
|
-2% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2021-03-05 |
4 |
OE |
$0.28 |
$7,200 |
D/D |
20,000 |
66,076 |
|
- |
|
Gordon Stephen |
Chief Financial Officer |
|
2021-02-16 |
4 |
AS |
$31.33 |
$313,300 |
D/D |
(10,000) |
0 |
|
18% |
|
Gordon Stephen |
Chief Financial Officer |
|
2021-02-16 |
4 |
OE |
$0.67 |
$6,700 |
D/D |
10,000 |
10,000 |
|
- |
|
Sullivan John F |
VP of Quality & Engineering |
|
2021-02-09 |
4 |
AS |
$32.78 |
$282,188 |
D/D |
(8,600) |
10,828 |
|
-10% |
|
Sullivan John F |
VP of Quality & Engineering |
|
2021-02-09 |
4 |
OE |
$0.28 |
$2,408 |
D/D |
8,600 |
19,428 |
|
- |
|
Riva Capital Management Iii, Llc |
10% Owner |
|
2021-02-09 |
4 |
S |
$33.32 |
$26,208,734 |
I/I |
(786,664) |
2,624,712 |
|
10% |
|
Tobin James R |
Director |
|
2021-02-09 |
4 |
AS |
$32.80 |
$333,786 |
I/I |
(10,168) |
424,637 |
|
-10% |
|
Gordon Stephen |
Chief Financial Officer |
|
2021-02-08 |
4 |
AS |
$25.01 |
$250,100 |
D/D |
(10,000) |
0 |
|
15% |
|
Gordon Stephen |
Chief Financial Officer |
|
2021-02-08 |
4 |
OE |
$0.67 |
$957 |
D/D |
1,429 |
1,429 |
|
- |
|
Riva Capital Management Iii, Llc |
10% Owner |
|
2021-02-08 |
4 |
S |
$26.24 |
$2,321,705 |
I/I |
(88,483) |
3,411,376 |
|
-15% |
|
Sullivan John F |
VP of Quality & Engineering |
|
2021-01-19 |
4 |
AS |
$22.12 |
$212,728 |
D/D |
(9,617) |
10,828 |
|
12% |
|
Sullivan John F |
VP of Quality & Engineering |
|
2021-01-19 |
4 |
OE |
$0.39 |
$3,751 |
D/D |
9,617 |
20,445 |
|
- |
|
Hassanein Waleed H |
President & CEO |
|
2021-01-05 |
4 |
OE |
$0.39 |
$48,131 |
D/D |
123,414 |
338,843 |
|
- |
|
Gordon Stephen |
Chief Financial Officer |
|
2021-01-04 |
4 |
AS |
$20.00 |
$23,680 |
D/D |
(1,184) |
8,371 |
|
14% |
|
Gordon Stephen |
Chief Financial Officer |
|
2020-12-31 |
4 |
AS |
$20.00 |
$176,320 |
D/D |
(8,816) |
9,755 |
|
13% |
|
Sullivan John F |
VP of Quality & Engineering |
|
2020-12-21 |
4 |
AS |
$17.99 |
$17,990 |
D/D |
(1,000) |
10,828 |
|
56% |
|
Sullivan John F |
VP of Quality & Engineering |
|
2020-12-16 |
4 |
OE |
$0.39 |
$390 |
D/D |
1,000 |
11,828 |
|
- |
|
Sullivan John F |
VP of Quality & Engineering |
|
2020-12-15 |
4 |
AS |
$16.63 |
$49,890 |
D/D |
(3,000) |
10,828 |
|
63% |
|
Sullivan John F |
VP of Quality & Engineering |
|
2020-12-15 |
4 |
OE |
$0.39 |
$1,170 |
D/D |
3,000 |
13,828 |
|
- |
|
Provost Miriam |
VP of US Regulatory & FDA Rel. |
|
2020-12-11 |
4 |
OE |
$3.22 |
$14,812 |
D/D |
4,600 |
4,600 |
|
- |
|
Carey John F |
VP of Operations |
|
2020-09-01 |
4 |
AS |
$17.59 |
$35,180 |
D/D |
(2,000) |
3,200 |
|
3% |
|
388 Records found
|
|
Page 13 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|